AF
EXAS

Amalgamated Financial’s Exact Sciences EXAS Stock Holding History

Amalgamated Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.34M Buy
+19,110
New +$1.4M 0.01% 1065

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Financial's EXAS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Exact Sciences (EXAS) in Q1 2022: 19,110 shares worth $1.34M. The stake represents 0.01% of the portfolio and ranks #1065 among its holdings.

559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Amalgamated Financial held 19,110 shares of Exact Sciences worth $1.34M as of Q1 2022.
  • Exact Sciences was a new Amalgamated Financial position in Q1 2022.
  • Exact Sciences made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1065 holding.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.